Aesthetik Engineers Ltd.
•₹ 721.12%
2026-08-21
PROS
- Company has a healthy return on capital (ROCE) of 24.3%
- Company has a good return on equity (ROE) track record: 3 Years ROE 24.0%
- Company comfortably covers its interest (9.3x coverage)
- Company maintains a comfortable, low leverage position
CONS
- Receivables are growing faster than sales - a possible quality concern
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.29x)
- Working capital days have increased from 67 to 120 days
- Debtor days have increased from 37 to 66
- Though reporting repeated profits, the company pays out little dividend (0.0%)
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | THEJO | 2124.60 | 41.15 | 2304.66 | 0.24 | 15.23 | 56.09 | 177.61 | 31.02 | 21.79 | 14.23 |
| 2. | SOUTHWEST | 217.30 | 17.76 | 709.52 | 0.00 | 9.34 | 288.51 | 61.68 | 53.36 | 13.57 | 26.33 |
| 3. | AESTHETIK | 71.20 | 17.21 | 122.61 | 0.00 | — | — | — | — | 21.83 | — |
| 4. | AHLADA | 40.82 | 0.00 | 52.74 | 0.00 | 1.75 | 203.29 | 240.26 | 778.98 | 2.69 | 13.52 |
| 5. | TMTINDIA | 8.45 | 0.00 | 4.19 | 0.00 | -0.05 | 36.25 | 0.00 | — | -110.50 | — |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
No quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 40 | 61 | 66 | |
| 38 | 53 | 58 | |
| Operating Profit | 2 | 8 | 10 |
| OPM % | 6 | 13 | 14 |
| Other Income | 0 | 0 | 1 |
| Interest | 1 | 1 | 1 |
| Depreciation | 0 | 1 | 1 |
| 2 | 7 | 8 | |
| Tax % | 25 | 23 | 25 |
| Net Profit | 1 | 5 | 6 |
| EPS | 13 | 4 | 3 |
| Dividend Payout % | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 |
| Share of Associates | 0 | -0 | 0 |
| Adjusted EPS | 1 | 4 | 3 |
| Minority Interest | 0 | 0 | 0 |
| Share of Associates | 0 | -0 | 0 |
| Adjusted EPS | 1 | 4 | 3 |
Mar 2023
- 40
- 38
- Operating Profit
- 2
- OPM %
- 6
- Other Income
- 0
- Interest
- 1
- Depreciation
- 0
- 2
- Tax %
- 25
- Net Profit
- 1
- EPS
- 13
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2024
- 61
- 53
- Operating Profit
- 8
- OPM %
- 13
- Other Income
- 0
- Interest
- 1
- Depreciation
- 1
- 7
- Tax %
- 23
- Net Profit
- 5
- EPS
- 4
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- -0
- Adjusted EPS
- 4
- Minority Interest
- 0
- Share of Associates
- -0
- Adjusted EPS
- 4
Mar 2025
- 66
- 58
- Operating Profit
- 10
- OPM %
- 14
- Other Income
- 1
- Interest
- 1
- Depreciation
- 1
- 8
- Tax %
- 25
- Net Profit
- 6
- EPS
- 3
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- -40%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 24%
- Last Year:
- 19%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| LIABILITIES | - | - | - |
| Equity Capital | 1 | 13 | 17 |
| 9 | 2 | 27 | |
| 5 | 4 | 8 | |
| Trade Payables | 4 | 5 | 6 |
| 5 | 7 | 4 | |
| Total Liabilities | 24 | 31 | 62 |
| ASSETS | - | - | - |
| 4 | 4 | 14 | |
| 0 | 0 | 6 | |
| 5 | 11 | 9 | |
| 0 | 5 | 19 | |
| Cash & Bank | 0 | 1 | 3 |
| 16 | 9 | 12 | |
| Total Assets | 24 | 31 | 62 |
| Total Debt | 6 | 8 | 10 |
| Net Working Capital | 1 | 11 | 22 |
| Contingent Liabilities | 0 | 0 | 0 |
| Book Value per Share | 114.21 | 11.73 | 25.75 |
| Face Value | 10.00 | 10.00 | 10.00 |
| Total Debt | 6 | 8 | 10 |
| Net Working Capital | 1 | 11 | 22 |
| Contingent Liabilities | 0 | 0 | 0 |
| Book Value per Share | 114.21 | 11.73 | 25.75 |
| Face Value | 10.00 | 10.00 | 10.00 |
Mar 2023
- Equity Capital
- 1
- 9
- 5
- Trade Payables
- 4
- 5
- Total Liabilities
- 24
- 4
- 0
- 5
- 0
- Cash & Bank
- 0
- 16
- Total Assets
- 24
- Total Debt
- 6
- Net Working Capital
- 1
- Contingent Liabilities
- 0
- Book Value per Share
- 114.21
- Face Value
- 10.00
- Total Debt
- 6
- Net Working Capital
- 1
- Contingent Liabilities
- 0
- Book Value per Share
- 114.21
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 13
- 2
- 4
- Trade Payables
- 5
- 7
- Total Liabilities
- 31
- 4
- 0
- 11
- 5
- Cash & Bank
- 1
- 9
- Total Assets
- 31
- Total Debt
- 8
- Net Working Capital
- 11
- Contingent Liabilities
- 0
- Book Value per Share
- 11.73
- Face Value
- 10.00
- Total Debt
- 8
- Net Working Capital
- 11
- Contingent Liabilities
- 0
- Book Value per Share
- 11.73
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 17
- 27
- 8
- Trade Payables
- 6
- 4
- Total Liabilities
- 62
- 14
- 6
- 9
- 19
- Cash & Bank
- 3
- 12
- Total Assets
- 62
- Total Debt
- 10
- Net Working Capital
- 22
- Contingent Liabilities
- 0
- Book Value per Share
- 25.75
- Face Value
- 10.00
- Total Debt
- 10
- Net Working Capital
- 22
- Contingent Liabilities
- 0
- Book Value per Share
- 25.75
- Face Value
- 10.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 3 | -2 | 3 | |
| Cash from Investing | -1 | 1 | -21 |
| Cash from Financing | -2 | 2 | 20 |
| -0 | 1 | 2 | |
| Free Cash Flow | 3 | -3 | -8 |
| OCF / Net Profit | 2.96 | -0.50 | 0.46 |
| Cumulative 5-Year FCF | 0 | 0 | 0 |
| OCF / Net Profit | 2.96 | -0.50 | 0.46 |
| Cumulative 5-Year FCF | 0 | 0 | 0 |
Mar 2023
- 3
- Cash from Investing
- -1
- Cash from Financing
- -2
- -0
- Free Cash Flow
- 3
- OCF / Net Profit
- 2.96
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.96
- Cumulative 5-Year FCF
- 0
Mar 2024
- -2
- Cash from Investing
- 1
- Cash from Financing
- 2
- 1
- Free Cash Flow
- -3
- OCF / Net Profit
- -0.50
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.50
- Cumulative 5-Year FCF
- 0
Mar 2025
- 3
- Cash from Investing
- -21
- Cash from Financing
- 20
- 2
- Free Cash Flow
- -8
- OCF / Net Profit
- 0.46
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.46
- Cumulative 5-Year FCF
- 0
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| PER SHARE | - | - | - |
| EPS (₹) | 13.34 | 3.96 | 3.28 |
| Book Value (₹) | 114.21 | 11.73 | 25.75 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 1.15 | 4.39 | 3.93 |
| PROFITABILITY | - | - | - |
| Operating Margin % | 6.10% | 12.73% | 13.14% |
| Net Margin % | 2.81% | 8.28% | 8.53% |
| ROE % | 11.68% | 41.09% | 19.08% |
| ROCE % | 13.54% | 37.45% | 21.83% |
| 4.61% | 18.30% | 12.15% | |
| EFFICIENCY | - | - | - |
| Debtor Days | 66 | 37 | 66 |
| Inventory Days | 44 | 48 | 56 |
| Payable Days | 48 | 38 | 42 |
| 62 | 46 | 80 | |
| FINANCIAL HEALTH | - | - | - |
| Debt to Equity (x) | 0.61x | 0.57x | 0.22x |
| Interest Coverage (x) | 3.51x | 9.76x | 9.32x |
| 1.09x | 1.97x | 2.28x | |
| GROWTH | - | - | - |
| Revenue Growth % | 0.00% | 51.76% | 9.08% |
| Operating Profit Growth % | 0.00% | 219.89% | 22.36% |
| Net Profit Growth % | 0.00% | 346.76% | 12.29% |
| 0.00% | -70.34% | -17.13% | |
| VALUATION | - | - | - |
| P/E (x) | 0.00x | 0.00x | 22.93x |
| P/B (x) | 0.00x | 0.00x | 2.92x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% |
| 0.00x | 2.54x | 14.25x |
Mar 2023
- EPS (₹)
- 13.34
- Book Value (₹)
- 114.21
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 1.15
- Operating Margin %
- 6.10%
- Net Margin %
- 2.81%
- ROE %
- 11.68%
- ROCE %
- 13.54%
- 4.61%
- Debtor Days
- 66
- Inventory Days
- 44
- Payable Days
- 48
- 62
- Debt to Equity (x)
- 0.61x
- Interest Coverage (x)
- 3.51x
- 1.09x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 3.96
- Book Value (₹)
- 11.73
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 4.39
- Operating Margin %
- 12.73%
- Net Margin %
- 8.28%
- ROE %
- 41.09%
- ROCE %
- 37.45%
- 18.30%
- Debtor Days
- 37
- Inventory Days
- 48
- Payable Days
- 38
- 46
- Debt to Equity (x)
- 0.57x
- Interest Coverage (x)
- 9.76x
- 1.97x
- Revenue Growth %
- 51.76%
- Operating Profit Growth %
- 219.89%
- Net Profit Growth %
- 346.76%
- -70.34%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 2.54x
Mar 2025
- EPS (₹)
- 3.28
- Book Value (₹)
- 25.75
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 3.93
- Operating Margin %
- 13.14%
- Net Margin %
- 8.53%
- ROE %
- 19.08%
- ROCE %
- 21.83%
- 12.15%
- Debtor Days
- 66
- Inventory Days
- 56
- Payable Days
- 42
- 80
- Debt to Equity (x)
- 0.22x
- Interest Coverage (x)
- 9.32x
- 2.28x
- Revenue Growth %
- 9.08%
- Operating Profit Growth %
- 22.36%
- Net Profit Growth %
- 12.29%
- -17.13%
- P/E (x)
- 22.93x
- P/B (x)
- 2.92x
- Dividend Yield %
- 0.00%
- 14.25x
Documents
Announcements
Nothing filed yet.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Aug 2025

